Related references
Note: Only part of the references are listed.Subsequent malignant neoplasms in the childhood cancer survivor study: Occurrence of cancer types in which human papillomavirus is an established etiologic risk factor
Tara O. Henderson et al.
CANCER (2022)
Astragaloside IV suppresses migration and invasion of TGF-beta(1)-induced human hepatoma HuH-7 cells by regulating Nrf2/HO-1 and TGF-beta(1)/Smad3 pathways
Lili Li et al.
NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY (2022)
Prognostic and Immunological Roles of MMP-9 in Pan-Cancer
Yudan Zeng et al.
BIOMED RESEARCH INTERNATIONAL (2022)
Astragaloside IV enhances the sensibility of lung adenocarcinoma cells to bevacizumab by inhibiting autophagy
Liang Li et al.
DRUG DEVELOPMENT RESEARCH (2022)
Roles of Nitric Oxide in Brain Ischemia and Reperfusion
Yijie Wang et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2022)
Role of Peritoneal Mesothelial Cells in the Progression of Peritoneal Metastases
Junliang Li et al.
CANCERS (2022)
Astragaloside IV alleviates silica-induced pulmonary fibrosis via inactivation of the TGF-β1/Smad2/3 signaling pathway
Nannan Li et al.
INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE (2021)
Astragaloside IV Synergizing with Ferulic Acid Ameliorates Pulmonary Fibrosis by TGF-β1/Smad3 Signaling
Jiahuan Tong et al.
EVIDENCE-BASED COMPLEMENTARY AND ALTERNATIVE MEDICINE (2021)
Astragaloside IV protects against podocyte apoptosis by inhibiting oxidative stress via activating PPARγ-Klotho-FoxO1 axis in diabetic nephropathy
Lina Xing et al.
LIFE SCIENCES (2021)
Astragaloside IV antagonizes M2 phenotype macrophage polarization-evoked ovarian cancer cell malignant progression by suppressing the HMGB1-TLR4 axis
Xue Wang et al.
MOLECULAR IMMUNOLOGY (2021)
Investigating the Role of Indoleamine 2,3-Dioxygenase in Acute Myeloid Leukemia: A Systematic Review
Georgia Wells et al.
FRONTIERS IN IMMUNOLOGY (2021)
TGF-β Signaling and Resistance to Cancer Therapy
Maoduo Zhang et al.
FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY (2021)
Evaluation of astragaloside IV in hepatic fibrosis A meta-analysis
Zhongying Han et al.
MEDICINE (2021)
Signal strength controls the rate of polarization within CTLs during killing
Gordon L. Frazer et al.
JOURNAL OF CELL BIOLOGY (2021)
Astragaloside IV prevents acute myocardial infarction by inhibiting the TLR4/MyD88/NF-κB signaling pathway
Hui Shi et al.
JOURNAL OF FOOD BIOCHEMISTRY (2021)
Discovery of IACS-9779 and IACS-70465 as Potent Inhibitors Targeting Indoleamine 2,3-Dioxygenase 1 (IDO1) Apoenzyme
Matthew M. Hamilton et al.
JOURNAL OF MEDICINAL CHEMISTRY (2021)
Accelerated Bone Regeneration by Astragaloside IV through Stimulating the Coupling of Osteogenesis and Angiogenesis
Feng Wang et al.
INTERNATIONAL JOURNAL OF BIOLOGICAL SCIENCES (2021)
Astragaloside IV inhibits cardiac fibrosis via miR-135a-TRPM7-TGF-beta/Smads pathway
Yanchun Wei et al.
JOURNAL OF ETHNOPHARMACOLOGY (2020)
A review of cancer immunotherapy toxicity
Lucy Boyce Kennedy et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2020)
Quantitative proteomics analysis of differentially expressed proteins induced by astragaloside IV in cervical cancer cell invasion
Chenglai Xia et al.
CELLULAR & MOLECULAR BIOLOGY LETTERS (2020)
Astragaloside IV inhibits astrocyte senescence: implication in Parkinson's disease
Mei-Ling Xia et al.
JOURNAL OF NEUROINFLAMMATION (2020)
A Review of the Pharmacological Action of Astragalus Polysaccharide
Yijun Zheng et al.
FRONTIERS IN PHARMACOLOGY (2020)
Discovery and structure-activity relationship studies of 1-aryl-1H-naphtho[2,3-d][1,2,3]triazole-4,9-dione derivatives as potent dual inhibitors of indoleamine 2,3-dioxygenase 1 (IDO1) and trytophan 2,3-dioxygenase (TDO)
Shulei Pan et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2020)
Bevacizumab (Avastin®) in cancer treatment: A review of 15 years of clinical experience and future outlook
Josep Garcia et al.
CANCER TREATMENT REVIEWS (2020)
Astragaloside IV Exerts Anti-tumor Effect on Murine Colorectal Cancer by Re-educating Tumor-Associated Macrophage
Feng Liu et al.
ARCHIVUM IMMUNOLOGIAE ET THERAPIAE EXPERIMENTALIS (2020)
Astragaloside IV acts through multi-scale mechanisms to effectively reduce diabetic nephropathy
Enyu Wang et al.
PHARMACOLOGICAL RESEARCH (2020)
Astragaloside IV Derivative (LS-102) Alleviated Myocardial Ischemia Reperfusion Injury by Inhibiting Drp1Ser616 Phosphorylation-Mediated Mitochondrial Fission
Li Chen et al.
FRONTIERS IN PHARMACOLOGY (2020)
Preliminary study on the anti-apoptotic mechanism of Astragaloside IV on radiation-induced brain cells
Xin Liu et al.
INTERNATIONAL JOURNAL OF IMMUNOPATHOLOGY AND PHARMACOLOGY (2020)
Astragaloside IV Induces Apoptosis, G1-Phase Arrest and Inhibits Anti-apoptotic Signaling in Hepatocellular Carcinoma
Chun-Min Su et al.
IN VIVO (2020)
Astragaloside IV enhances taxol chemosensitivity of breast cancer via caveolin-1-targeting oxidant damage
Yifeng Zheng et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2019)
Astragaloside IV Inhibits the Progression of Non-Small Cell Lung Cancer Through the Akt/GSK-3β/β-Catenin Pathway
Liwei Jia et al.
ONCOLOGY RESEARCH (2019)
Characterization of M1 and M2 polarization phenotypes in peritoneal macrophages after treatment with graphene oxide nanosheets
Maria Jose Feito et al.
COLLOIDS AND SURFACES B-BIOINTERFACES (2019)
The Role of Astragaloside IV against Cerebral Ischemia/Reperfusion Injury: Suppression of Apoptosis via Promotion of P62-LC3-Autophagy
Yi Zhang et al.
MOLECULES (2019)
The Vav GEF Family: An Evolutionary and Functional Perspective
Sonia Rodriguez-Fdez et al.
CELLS (2019)
Molecular machinery and interplay of apoptosis and autophagy in coronary heart disease
Yan Dong et al.
JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY (2019)
Pharmacokinetics Comparison, Intestinal Absorption and Acute Toxicity Assessment of a Novel Water-Soluble Astragaloside IV Derivative (Astragalosidic Acid, LS-102)
Lin-Sen Qing et al.
EUROPEAN JOURNAL OF DRUG METABOLISM AND PHARMACOKINETICS (2019)
New insights into the mechanisms of epithelial-mesenchymal transition and implications for cancer
Anushka Dongre et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2019)
Astragaloside IV inhibits glucose-induced epithelial-mesenchymal transition of podocytes through autophagy enhancement via the SIRT-NF-κB p65 axis
Xiaolei Wang et al.
SCIENTIFIC REPORTS (2019)
HDAC1,2 inhibition and doxorubicin impair Mre11-dependent DNA repair and DISC to override BCR-ABL1-driven DSB repair in Philadelphia chromosome-positive B-cell precursor acute lymphoblastic leukemia
S. Tharkar-Promod et al.
LEUKEMIA (2018)
Salvianolic acid A, a novel PI3K/Akt inhibitor, induces cell apoptosis and suppresses tumor growth in acute myeloid leukemia
Renzhi Pei et al.
LEUKEMIA & LYMPHOMA (2018)
Celastrol inhibits cancer metastasis by suppressing M2-like polarization of macrophages
Yuening Yang et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2018)
Astragaloside IV inhibits cell proliferation of colorectal cancer cell lines through down-regulation of B7-H3
Shuxia Wang et al.
BIOMEDICINE & PHARMACOTHERAPY (2018)
Astragaloside IV inhibits cell migration and viability of hepatocellular carcinoma cells via suppressing long noncoding RNA ATB
Yaling Li et al.
BIOMEDICINE & PHARMACOTHERAPY (2018)
Ginsenoside F1 suppresses astrocytic senescence-associated secretory phenotype
Jingang Hou et al.
CHEMICO-BIOLOGICAL INTERACTIONS (2018)
Targeting the Stat6 pathway in tumor-associated macrophages reduces tumor growth and metastatic niche formation in breast cancer
Karin Binnemars-Postma et al.
FASEB JOURNAL (2018)
Macrophage plasticity, polarization, and function in health and disease
Abbas Shapouri-Moghaddam et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2018)
CANCER Re-educating tumour-associated macrophages with nanoparticles
Megan Cully
NATURE REVIEWS DRUG DISCOVERY (2018)
Astragaloside IV inhibits TGF-1-induced epithelial-mesenchymal transition through inhibition of the PI3K/Akt/NF-B pathway in gastric cancer cells
Jihong Zhu et al.
PHYTOTHERAPY RESEARCH (2018)
Anti-angiogenesis for cancer: Current status and prospects
Massimo Russo et al.
THROMBOSIS RESEARCH (2018)
Astragaloside IV inhibits lung cancer progression and metastasis by modulating macrophage polarization through AMPK signaling
Fei Xu et al.
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2018)
Matrix Metalloproteinase-9 (MMP-9) as a Cancer Biomarker and MMP-9 Biosensors: Recent Advances
Hao Huang
SENSORS (2018)
Astragaloside IV/lncRNA-TUGI/TRAF5 signaling pathway participates in podocyte apoptosis of diabetic nephropathy rats
Xiao Lei et al.
DRUG DESIGN DEVELOPMENT AND THERAPY (2018)
Epithelial-to-mesenchymal transition in cancer: complexity and opportunities
Yun Zhang et al.
FRONTIERS OF MEDICINE (2018)
Research review on the pharmacological effects of astragaloside IV
Lei Li et al.
FUNDAMENTAL & CLINICAL PHARMACOLOGY (2017)
From inflammation to cancer
A. Korniluk et al.
IRISH JOURNAL OF MEDICAL SCIENCE (2017)
Identification of a Novel Human E-Cadherin Splice Variant and Assessment of Its Effects Upon EMT-Related Events
Maria Laura Matos et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2017)
Rewiring of the apoptotic TGF-β-SMAD/NFκB pathway through an oncogenic function of p27 in human papillary thyroid cancer
A. R. Garcia-Rendueles et al.
ONCOGENE (2017)
Deacetylation biocatalysis and elicitation by immobilized Penicillium canescens in Astragalus membranaceus hairy root cultures: towards the enhanced and sustainable production of astragaloside IV
Qing-Yan Gai et al.
PLANT BIOTECHNOLOGY JOURNAL (2017)
Epithelial derived-matrix metalloproteinase (MMP9) exhibits a novel defensive role of tumor suppressor in colitis associated cancer by activating MMP9-Notch1-ARF-p53 axis
Lewins Walter et al.
ONCOTARGET (2017)
Astragaloside IV inhibits breast cancer cell invasion by suppressing Vav3 mediated Rac1/MAPK signaling
Ke Jiang et al.
INTERNATIONAL IMMUNOPHARMACOLOGY (2017)
Exosomal miRNAs and miRNA dysregulation in cancer-associated fibroblasts
Fengming Yang et al.
MOLECULAR CANCER (2017)
Astragaloside IV downregulates the expression of MDR1 in Bel-7402/FU human hepatic cancer cells by inhibiting the JNK/c-Jun/AP-1 signaling pathway
Pei-Pei Wang et al.
MOLECULAR MEDICINE REPORTS (2017)
Astragalosidic Acid: A New Water-Soluble Derivative of Astragaloside IV Prepared Using Remarkably Simple TEMPO-Mediated Oxidation
Lin-Sen Qing et al.
MOLECULES (2017)
Tumour-associated macrophages as treatment targets in oncology
Alberto Mantovani et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2017)
Astragaloside IV inhibits metastasis in hepatoma cells through the suppression of epithelial-mesenchymal transition via the Akt/GSK-3β/β-catenin pathway
Cheng-Dong Qin et al.
ONCOLOGY REPORTS (2017)
3-Phosphoinositide Dependent Protein Kinase-1 (PDK-1) Promotes Migration and Invasion in Gastric Cancer Cells Through Activating the NF-κB Pathway
Ning Wu et al.
ONCOLOGY RESEARCH (2017)
Astragaloside IV sensitizes non-small cell lung cancer cells to gefitinib potentially via regulation of SIRT6
Peng-Chen Dai et al.
TUMOR BIOLOGY (2017)
Astragaloside IV inhibits pathological functions of gastric cancer-associated fibroblasts
Zhen-Fei Wang et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2017)
MiR-23a promotes TGF-β1-induced EMT and tumor metastasis in breast cancer cells by directly targeting CDH1 and activating Wnt/β-catenin signaling
Fei Ma et al.
ONCOTARGET (2017)
Matrix metalloproteinase MMP9 maintains epithelial barrier function and preserves mucosal lining in colitis associated cancer
Adani Pujada et al.
ONCOTARGET (2017)
Toll-Like Receptor Ligands and Interferon-γ Synergize for Induction of Antitumor M1 Macrophages
Elisabeth Mueller et al.
FRONTIERS IN IMMUNOLOGY (2017)
HIV and drug abuse mediate astrocyte senescence in a β-catenin-dependent manner leading to neuronal toxicity
Chunjiang Yu et al.
AGING CELL (2017)
Astragaloside IV inhibits progression of glioma via blocking MAPK/ERK signaling pathway
Bin Li et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2017)
Dioscin suppresses TGF-b1-induced epithelial-mesenchymal transition and suppresses A549 lung cancer migration and invasion
Won-Chul Lim et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2017)
Co-Activation of TGFP and Wnt Signalling Pathways Abrogates EMT in Ovarian Cancer Cells
Tulika Mitra et al.
CELLULAR PHYSIOLOGY AND BIOCHEMISTRY (2017)
Apoptosis as anticancer mechanism: function and dysfunction of its modulators and targeted therapeutic strategies
Giuseppa Pistritto et al.
AGING-US (2016)
The PI3K/AKT Pathway as a Target for Cancer Treatment
Ingrid A. Mayer et al.
ANNUAL REVIEW OF MEDICINE, VOL 67 (2016)
Astragaloside IV Enhances Cisplatin Chemosensitivity in Non-Small Cell Lung Cancer Cells Through Inhibition of B7-H3
Cheng-Shi He et al.
CELLULAR PHYSIOLOGY AND BIOCHEMISTRY (2016)
Astragaloside IV Enhances Cisplatin Chemosensitivity in Human Colorectal Cancer via Regulating NOTCH3
Tao Xie et al.
ONCOLOGY RESEARCH (2016)
Overexpression of SASH1 Inhibits TGF-β1-Induced EMT in Gastric Cancer Cells
Wei Zong et al.
ONCOLOGY RESEARCH (2016)
Potential neuroprotection of protodioscin against cerebral ischemia-reperfusion injury in rats through intervening inflammation and apoptosis
Xinxin Zhang et al.
STEROIDS (2016)
Crosstalk between TGF-β signaling and miRNAs in breast cancer metastasis
Wei Chen et al.
TUMOR BIOLOGY (2016)
TGF-β1 functional polymorphisms: a review
Guilherme Cesar Martelossi Cebinelli et al.
EUROPEAN CYTOKINE NETWORK (2016)
Research progress of indoleamine 2,3-dioxygenase inhibitors
Tianze Jiang et al.
FUTURE MEDICINAL CHEMISTRY (2015)
Tracking miRNAs' Footprints in Tumor-Microenvironment Interactions: Insights and Implications for Targeted Cancer Therapy
Nazila Nouraee et al.
GENES CHROMOSOMES & CANCER (2015)
SIRT6 expression is associated with poor prognosis and chemosensitivity in patients with non-small cell lung cancer
Yoko Azuma et al.
JOURNAL OF SURGICAL ONCOLOGY (2015)
FHIT loss confers cisplatin resistance in lung cancer via the AKT/NF-κB/Slug-mediated PUMA reduction (vol 34, pg 2505, 2015)
D-W Wu et al.
ONCOGENE (2015)
Macrophages and cancer: from mechanisms to therapeutic implications
Renato Ostuni et al.
TRENDS IN IMMUNOLOGY (2015)
Microlocalization of CD68+ tumor-associated macrophages in tumor stroma correlated with poor clinical outcomes in oral squamous cell carcinoma patients
Yan-Hong Ni et al.
TUMOR BIOLOGY (2015)
Molecular mechanism underlying the tumor-promoting functions of carcinoma-associated fibroblasts
Yali Han et al.
TUMOR BIOLOGY (2015)
Activation of β-catenin signalling by TFF1 loss promotes cell proliferation and gastric tumorigenesis
Mohammed Soutto et al.
GUT (2015)
Adenosine 5′-Monophosphate-Activated Protein Kinase Regulates IL-10-Mediated Anti-Inflammatory Signaling Pathways in Macrophages
Yanfang Peipei Zhu et al.
JOURNAL OF IMMUNOLOGY (2015)
Astragaloside IV inhibits migration and invasion in human lung cancer A549 cells via regulating PKC-α-ERK1/2-NF-κB pathway
Xudong Cheng et al.
INTERNATIONAL IMMUNOPHARMACOLOGY (2014)
Astragaloside IV inhibits progression of lung cancer by mediating immune function of Tregs and CTLs by interfering with IDO
Anle Zhang et al.
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY (2014)
Astragaloside IV reduces the expression level of P-glycoprotein in multidrug resistant human hepatic cancer cell lines
Pei-Pei Wang et al.
MOLECULAR MEDICINE REPORTS (2014)
Profiling the Metabolism of Astragaloside IV by Ultra Performance Liquid Chromatography Coupled with Quadrupole/Time-of-Flight Mass Spectrometry
Xu-Dong Cheng et al.
MOLECULES (2014)
Oncogenic roles of EMT-inducing transcription factors
Alain Puisieux et al.
NATURE CELL BIOLOGY (2014)
Molecular mechanisms of epithelial-mesenchymal transition
Samy Lamouille et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2014)
The cellular and molecular origin of tumor-associated macrophages
Ruth A. Franklin et al.
SCIENCE (2014)
From monocytes to M1/M2 macrophages: phenotypical vs. functional differentiation
Paola Italiani et al.
FRONTIERS IN IMMUNOLOGY (2014)
Downregulation of microRNA-214 and overexpression of FGFR-1 contribute to hepatocellular carcinoma metastasis
Jian Wang et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2013)
SIRT6 modulates paclitaxel and epirubicin resistance and survival in breast cancer
Mattaka Khongkow et al.
CARCINOGENESIS (2013)
Cancer-Related Inflammation
Juliana Candido et al.
JOURNAL OF CLINICAL IMMUNOLOGY (2013)
Abnormal expression of miR-301a in gastric cancer associated with progression and poor prognosis
Xiao-Dong Xu et al.
JOURNAL OF SURGICAL ONCOLOGY (2013)
Pharmacokinetics and tolerance of toal astragalosides after intravenous infusion of astragalosides injection in healthy Chinese volunteers
Meijuan Xu et al.
PHYTOMEDICINE (2013)
Therapy for Fibrotic Diseases: Nearing the Starting Line
Scott L. Friedman et al.
SCIENCE TRANSLATIONAL MEDICINE (2013)
MicroRNA-214 Suppresses Growth and Invasiveness of Cervical Cancer Cells by Targeting UDP-N-acetyl-α-D-galactosamine: Polypeptide N-Acetylgalactosaminyltransferase 7
Rui-Qing Peng et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2012)
The experimental study of Astragalus membranaceus on meridian tropsim: The distribution study of astragaloside IV in rat tissues
Yan-xu Chang et al.
JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES (2012)
Hallmarks of Cancer: The Next Generation
Douglas Hanahan et al.
CELL (2011)
Macrophage regulation of tumor angiogenesis: Implications for cancer therapy
Mario Leonardo Squadrito et al.
MOLECULAR ASPECTS OF MEDICINE (2011)
Comparative Investigations on the Protective Effects of Rhodioside, Ciwujianoside-B and Astragaloside IV on Radiation Injuries of the Hematopoietic System in Mice
Yu-Rong Li et al.
PHYTOTHERAPY RESEARCH (2011)
Matrix Metalloproteinase-9 Functions as a Tumor Suppressor in Colitis-Associated Cancer
Pallavi Garg et al.
CANCER RESEARCH (2010)
Carcinoma-associated fibroblasts are a rate-limiting determinant for tumour progression
Masayuki Shimoda et al.
SEMINARS IN CELL & DEVELOPMENTAL BIOLOGY (2010)
Macrophages: Master Regulators of Inflammation and Fibrosis
Thomas A. Wynn et al.
SEMINARS IN LIVER DISEASE (2010)
Alternative Activation of Macrophages: An Immunologic Functional Perspective
Fernando O. Martinez et al.
ANNUAL REVIEW OF IMMUNOLOGY (2009)
Effect of staurosporine on the mobility and invasiveness of lung adenocarcinoma A549 cells: an in vitro study
Yanyan Wang et al.
BMC CANCER (2009)
Plasma protein kinase C (PKC)α as a biomarker for the diagnosis of cancers
Jeong-Hun Kang et al.
CARCINOGENESIS (2009)
Gefitinib A Review of its Use in the Treatment of Locally Advanced/Metastatic Non-Small Cell Lung Cancer
Mark Sanford et al.
DRUGS (2009)
Class I histone deacetylases 1, 2 and 3 are highly expressed in renal cell cancer
Florian R. Fritzsche et al.
BMC CANCER (2008)
Adenosine 5′-Monophosphate-Activated Protein Kinase Promotes Macrophage Polarization to an Anti-Inflammatory Functional Phenotype
Duygu Sag et al.
JOURNAL OF IMMUNOLOGY (2008)
Protective role of autophagy in neonatal hypoxia-ischemia induced brain injury
Silvia Carloni et al.
NEUROBIOLOGY OF DISEASE (2008)
Immune escape as a fundamental trait of cancer: focus on IDO
G. C. Prendergast
ONCOGENE (2008)
Exploring the full spectrum of macrophage activation
David M. Mosser et al.
NATURE REVIEWS IMMUNOLOGY (2008)
VEGF-targeted therapy: mechanisms of anti-tumour activity
Lee M. Ellis et al.
NATURE REVIEWS CANCER (2008)
Subchronic toxicity studies of Radix Astragali extract in rats and dogs
Shu-Yi Yu et al.
JOURNAL OF ETHNOPHARMACOLOGY (2007)
MicroRNA-cancer connection: The beginning of a new tale
George Adrian Calin et al.
CANCER RESEARCH (2006)
Preclinical pharmacokinetics and tissue distribution of a natural cardioprotective agent astragaloside IV in rats and dogs
Wei-Dong Zhang et al.
LIFE SCIENCES (2006)
Tumour-associated macrophages are a distinct M2 polarised population promoting tumour progression: Potential targets of anti-cancer therapy
A Sica et al.
EUROPEAN JOURNAL OF CANCER (2006)
Targeting multidrug resistance in cancer
G Szakács et al.
NATURE REVIEWS DRUG DISCOVERY (2006)
Astragaloside IV exerts antiviral effects against coxsackievirus B3 by upregulating interferon-γ
YY Zhang et al.
JOURNAL OF CARDIOVASCULAR PHARMACOLOGY (2006)
Absorption enhancement study of astragaloside IV based on its transport mechanism in Caco-2 cells
C. R. Huang et al.
EUROPEAN JOURNAL OF DRUG METABOLISM AND PHARMACOKINETICS (2006)
Monocyte and macrophage heterogeneity
S Gordon et al.
NATURE REVIEWS IMMUNOLOGY (2005)
Epithelial-mesenchymal transition in development and cancer:: role of phosphatidylinositol 3′ kinase/AKT pathways
L Larue et al.
ONCOGENE (2005)
Notch signals control the fate of immature progenitor cells in the intestine
S Fre et al.
NATURE (2005)
Notch/γ-secretase inhibition turns proliferative cells in intestinal crypts and adenomas into goblet cells
JH van Es et al.
NATURE (2005)
Discovery and development of bevacizumab, an anti-VEGF antibody for treating cancer
N Ferrara et al.
NATURE REVIEWS DRUG DISCOVERY (2004)
The biology of VEGF and its receptors
N Ferrara et al.
NATURE MEDICINE (2003)
Issues and progress with protein kinase inhibitors for cancer treatment
J Dancey et al.
NATURE REVIEWS DRUG DISCOVERY (2003)
Distinct role of phosphatidylinositol 3-kinase and Rho family GTPases in Vav3-induced cell transformation, cell motility, and morphological changes
P Sachdev et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
Share Paper
